Journal article

Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: Twelve-month outcome

PD McGorry, B Nelson, LJ Phillips, HP Yuen, SM Francey, A Thampi, GE Berger, P Amminger, MB Simmons, D Kelly, AD Thompson, AR Yung

Journal of Clinical Psychiatry | Published : 2013

Abstract

Objective: The ultra-high risk clinical phenotype is associated with substantial distress and functional impairment and confers a greatly enhanced risk for transition to full-threshold psychosis. A range of interventions aimed at relieving current symptoms and functional impairment and reducing the risk of transition to psychosis has shown promising results, but the optimal type and sequence of intervention remain to be established. The aim of this study was to determine which intervention was most effective at preventing transition to psychosis: cognitive therapy plus low-dose risperidone, cognitive therapy plus placebo, or supportive therapy plus placebo. Method: A double-blind, randomized..

View full abstract

Grants

Funding Acknowledgements

Dr McGorry has served as a consultant to Bristol-Myers Squibb, Eli Lilly, Pfizer, Roche, Lundbeck, AstraZeneca, Sanofi-Synthelabo, and Janssen-Cilag and has received unrestricted research funding from Janssen-Cilag, Bristol-Myers Squibb, and AstraZeneca. Drs Phillips and Yung have received unrestricted research grant funding from Janssen Cilag. Dr Thompson has received unrestricted research grant funding from Janssen Cilag, Pfizer, and AstraZeneca. Drs Nelson, Francey, Thampi, Berger, and Amminger; Messrs Yuen and Kelly; and Ms Simmons report no potential conflict of interest.